Tonix Pharmaceuticals Announces Closing of $9.0 Million Public Offering
NEW YORK, Nov. 20, 2019 (GLOBE NEWSWIRE) — Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), clinical-stage biopharmaceutical […]
Yunji to Report Third Quarter 2019 Financial Results on December 2, 2019
HANGZHOU, China, Nov. 20, 2019 (GLOBE NEWSWIRE) — Yunji Inc. (“Yunji” or the “Company”) (NASDAQ: YJ), a leading membership-based social […]
Trevena Announces Publication of Results from Phase 3 “Real World” Safety Study for Oliceridine in The Journal of Pain Research
Safety and tolerability demonstrated in diverse patient populations and surgeriesCHESTERBROOK, Pa., Nov. 20, 2019 (GLOBE NEWSWIRE) — Trevena, Inc. (Nasdaq: […]
Wingstop Expands International Footprint to France
DALLAS, Nov. 20, 2019 (GLOBE NEWSWIRE) — Brescia Investissement SAS, a brand partner of Wingstop (NASDAQ: WING), the award-winning concept […]
TSX News -
Calibre Mining: Conversion of B2Gold’s US$10 Million Debenture
VANCOUVER, British Columbia, Nov. 20, 2019 (GLOBE NEWSWIRE) — Calibre Mining Corp. (TSX: CXB) (the “Company” or “Calibre”) announced that […]
TSX News -
Dynacor Announces 50% Increase to Its Quarterly Dividend
MONTREAL, Nov. 20, 2019 (GLOBE NEWSWIRE) — Dynacor Gold Mines Inc. (TSX: DNG / OTC: DNGDF) (Dynacor or the Corporation) […]
Emerald Health Therapeutics Responds to Inaccurate Allegations by Village Farms
VANCOUVER, British Columbia, Nov. 20, 2019 (GLOBE NEWSWIRE) — Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) today responded […]
James E. Wagner Cultivation Corporation Signs a Strategic Sales Agreement With Kindred Partners Inc.
KITCHENER, Ontario, Nov. 20, 2019 (GLOBE NEWSWIRE) — James E. Wagner Cultivation Corporation (“JWC” or the “Corporation”) (TSX VENTURE: JWCA; […]
Whitestone Welcomes Premier Omni-Retail Brand Sephora to Village Square at Dana Park in Mesa, Arizona
HOUSTON, Nov. 20, 2019 (GLOBE NEWSWIRE) — Sephora arrives at Village Square at Dana Park!Owned by LVMH Moët Hennessy Louis […]
Vertical Pharmaceuticals, LLC, an Osmotica Company, Announces Acceptance of New Drug Application by FDA for RVL-1201 (Oxymetazoline Hydrochloride Ophthalmic Solution, 0.1%) for Acquired Blepharoptosis (Droopy Eyelid)
BRIDGEWATER, N.J., Nov. 20, 2019 (GLOBE NEWSWIRE) — Vertical Pharmaceuticals, LLC (a subsidiary of Osmotica Pharmaceuticals plc (Nasdaq: OSMT) (“Osmotica” […]
